Middle East and Africa Multiplex Assays Market Companies Profiles, Size, Share, Growth, Trends and Forecast to 2026

October 2018 | 100 pages | ID: M6CF6714A8DEN
Data Bridge Market Research

Abstracts

Middle East & Africa multiplex assays market is expected to register a healthy CAGR of 6.3% in the forecast period of 2019 to 2026. The new market report contains data for historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation

By Products & Services (Reagents & Consumables, Instruments & Accessories, Software & Services), Type (Nucleic Acid Multiplex Assays, Protein Multiplex Assays, Cell-Based Multiplex Assays), Technology (Protein Microarray, Polymerase Chain Reaction, Multiplex Real-Time PCR, Flow Cytometry, Fluorescence Detection, Luminescence, Others), Application (Clinical Diagnostics, Research & Development), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Others), Geography (Middle East & Africa)

Major growing sectors under the Market Segmentation are as follows:

• In products & services, reagents & consumables segment are dominating this market as the assays are widely accepted and applicable in various healthcare sectors the reagents & consumables holds the largest market share.
• In type, the nucleic acid multiplex assays are highly sensitive and specific to diagnose human diseases such as cancer, autoimmune or infectious diseases.
• In technology, the protein microarray is the emerging technology in the multiplex assays which offers characterization of hundreds of thousands of proteins in a highly parallel and high-throughput way. However, polymerase chain reaction is growing in the market due to its higher throughput and more information in fewer samples. As well as its time saving and cost effective.
• In application, clinical diagnostics is growing more as there number of diseases increasing these days and treatment experiment is carries out more to treat the same and these processes are carries out under diagnostics division.
• In end user, hospitals segment is growing as people suffering from problem visit hospitals as early as possible for the treatment. Increasing population visit hospitals with increase number of problems to get treated as early as possible and therefore the hospitals segment is growing higher as compare to other segment.

The Key Market Players for global blood screening market are listed below:

• BD
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd
• Cepheid
• Siemens AG
• Hologic Inc.
• Luminex Corporation.
• MESO SCALE DIAGNOSTICS, LLC.
• QIAGEN
• PerkinElmer Inc.
• Illumina, Inc.
• AGENA BIOSCIENCE, INC.
• Olink
• Randox Laboratories Ltd.
• Bio-Techne.
• Agilent Technologies
• Sysmex Corporation

Contents

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 DBMR MARKET CHALLENGE MATRIX
2.9 THE CATEGORY VS TIME GRID
2.10 SECONDARY SOURCES
2.11 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS
  3.1.1 USE OF MULTIPLEX ASSAYS IN COMPANION DIAGNOSTICS
  3.1.2 ADVANTAGES OVER SINGLEPLEX AND TRADITIONAL ASSAYS
  3.1.3 INCREASING AWARENESS ABOUT MULTIFACTORIAL NATURE OF VARIOUS DISEASES
  3.1.4 GROWING APPLICATIONS OF MULTIPLEX ASSAYS
3.2 RESTRAINTS
  3.2.1 HIGH EQUIPMENT COSTS
  3.2.2 STRINGENT REGULATIONS AND STANDARDS
3.3 OPPORTUNITIES
  3.3.1 INCREASING VALIDATION OF BIOMARKERS IN MOLECULAR AND PROTEIN DIAGNOSTICS
  3.3.2 NEWLY AVAILABLE OR LAUNCHED PANELS FOR THE ASSAYS
3.4 CHALLENGES
  3.4.1 LACK OF PROFICIENT LABOUR TO HANDLE ADVANCED PROCEDURES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICES

6.1 OVERVIEW
6.2 REAGENTS & CONSUMABLES
6.3 INSTRUMENTS & ACCESSORIES
6.4 SOFTWARE & SERVICES

7 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET, BY TYPE

7.1 OVERVIEW
7.2 NUCLEIC ACID MULTIPLEX ASSAYS
  7.2.1 PLANAR NUCLEIC ASSAYS
  7.2.2 BEAD-BASED NUCLEIC ASSAYS
7.3 PROTEIN MULTIPLEX ASSAYS
  7.3.1 PLANAR PROTEIN ASSAYS
  7.3.2 BEAD-BASED PROTEIN ASSAYS
7.4 CELL-BASED MULTIPLEX ASSAYS

8 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY

8.1 OVERVIEW
8.2 PROTEIN MICROARRAY
8.3 POLYMERASE CHAIN REACTION
8.4 MULTIPLEX REAL-TIME PCR
8.5 FLOW CYTOMETRY
8.6 FLUORESCENCE DETECTION
8.7 LUMINESCENCE
8.8 OTHERS

9 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET, BY APPLICATION

9.1 OVERVIEW
9.2 CLINICAL DIAGNOSTICS
  9.2.1 CANCER
  9.2.2 CARDIOVASCULAR DISEASES
  9.2.3 METABOLISM & ENDOCRINOLOGY DISORDERS
  9.2.4 INFECTIOUS DISEASES
  9.2.5 NERVOUS SYSTEM DISORDERS
  9.2.6 AUTOIMMUNE DISEASES
  9.2.7 ALLERGIES
  9.2.8 OTHERS
9.3 RESEARCH & DEVELOPMENT
  9.3.1 DRUG DISCOVERY & DEVELOPMENT
  9.3.2 BIOMARKER DISCOVERY & VALIDATION

10 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET, BY END USER

10.1 OVERVIEW
10.2 HOSPITALS
10.3 CLINICAL LABORATORIES
10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIE
10.5 RESEARCH INSTITUTES
10.6 OTHERS

11 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET: BY GEOGRAPHY

11.1 MIDDLE EAST & AFRICA
  11.1.1 SOUTH AFRICA
  11.1.2 EGYPT
  11.1.3 SAUDI ARABIA
  11.1.4 UNITED ARAB EMIRATES
  11.1.5 ISRAEL
  11.1.6 REST OF MIDDLE EAST & AFRICA

12 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET, COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST-AND AFRICA

13 COMPANY PROFILE

13.1 THERMO FISHER SCIENTIFIC INC.
  13.1.1 COMPANY SNAPSHOT
  13.1.2 REVENUE ANALYSIS
  13.1.3 COMPANY SHARE ANALYSIS
  13.1.4 PRODUCT PORTFOLIO
  13.1.5 RECENT DEVELOPMENTS
13.2 F. HOFFMANN-LA ROCHE LTD
  13.2.1 COMPANY SNAPSHOT
  13.2.2 REVENUE ANALYSIS
  13.2.3 COMPANY SHARE ANALYSIS
  13.2.4 PRODUCT PORTFOLIO
  13.2.5 RECENT DEVELOPMENTS
13.3 BIO-RAD LABORATORIES, INC.
  13.3.1 COMPANY SNAPSHOT
  13.3.2 REVENUE ANALYSIS
  13.3.3 COMPANY SHARE ANALYSIS
  13.3.4 PRODUCT PORTFOLIO
  13.3.5 RECENT DEVELOPMENTS
13.4 QIAGEN
  13.4.1 COMPANY OVERVIEW
  13.4.2 REVENUE ANALYSIS
  13.4.3 COMPANY SHARE ANALYSIS
  13.4.4 PRODUCT PORTFOLIO
  13.4.5 RECENT DEVELOPMENTS
13.5 SIEMENS AG
  13.5.1 COMPANY SNAPSHOT
  13.5.2 REVENUE ANALYSIS
  13.5.3 PRODUCT PORTFOLIO
  13.5.4 RECENT DEVELOPMENTS
13.6 ABCAM PLC.
  13.6.1 COMPANY SNAPSHOT
  13.6.2 REVENUE ANALYSIS
  13.6.3 PRODUCT PORTFOLIO
  13.6.4 RECENT DEVELOPMENTS
13.7 AGENA BIOSCIENCE, INC.
  13.7.1 COMPANY SNAPSHOT
  13.7.2 GEOGRAPHICAL PRESENCE
  13.7.3 PRODUCT PORTFOLIO
  13.7.4 RECENT DEVELOPMENTS
13.8 AGILENT TECHNOLOGIES, INC.
  13.8.1 COMPANY SNAPSHOT
  13.8.2 REVENUE ANALYSIS
  13.8.3 PRODUCT PORTFOLIO
  13.8.4 RECENT DEVELOPMENTS
13.9 BD.
  13.9.1 COMPANY SNAPSHOT
  13.9.2 REVENUE ANALYSIS
  13.9.3 PRODUCT PORTFOLIO
  13.9.4 RECENT DEVELOPMENTS
13.10 BIO-TECHNE.
  13.10.1 COMPANY SNAPSHOT
  13.10.2 REVENUE ANALYSIS
  13.10.3 PRODUCT PORTFOLIO
  13.10.4 RECENT DEVELOPMENTS
13.11 BIOTEK INSTRUMENTS, INC.
  13.11.1 COMPANY SNAPSHOT
  13.11.2 GEOGRAPHICAL PRESENCE
  13.11.3 PRODUCT PORTFOLIO
  13.11.4 RECENT DEVELOPMENTS
13.12 HOLOGIC INC.
  13.12.1 COMPANY SNAPSHOT
  13.12.2 REVENUE ANALYSIS
  13.12.3 PRODUCT PORTFOLIO
  13.12.4 RECENT DEVELOPMENTS
13.13 ILLUMINA, INC.
  13.13.1 COMPANY SNAPSHOT
  13.13.2 REVENUE ANALYSIS
  13.13.3 PRODUCT PORTFOLIO
  13.13.4 RECENT DEVELOPMENTS
13.14 LUMINEX CORPORATION.
  13.14.1 COMPANY SNAPSHOT
  13.14.2 REVENUE ANALYSIS
  13.14.3 PRODUCT PORTFOLIO
  13.14.4 RECENT DEVELOPMENTS
13.15 MESO SCALE DIAGNOSTICS, LLC.
  13.15.1 COMPANY SNAPSHOT
  13.15.2 PRODUCT PORTFOLIO
  13.15.3 RECENT DEVELOPMENTS
13.16 OLINK
  13.16.1 COMPANY SNAPSHOT
  13.16.2 GEOGRAPHICAL PRESENCE
  13.16.3 PRODUCT PORTFOLIO
  13.16.4 RECENT DEVELOPMENTS
13.17 PERKINELMER INC.
  13.17.1 COMPANY SNAPSHOT
  13.17.2 REVENUE ANALYSIS
  13.17.3 PRODUCT PORTFOLIO
  13.17.4 RECENT DEVELOPMENTS
13.18 QUANTERIX
  13.18.1 COMPANY SNAPSHOT
  13.18.2 REVENUE ANALYSIS
  13.18.3 PRODUCT PORTFOLIO
  13.18.4 RECENT DEVELOPMENTS
13.19 QUEST DIAGNOSTICS INCORPORATED.
  13.19.1 COMPANY SNAPSHOT
  13.19.2 REVENUE ANALYSIS
  13.19.3 PRODUCT PORTFOLIO
  13.19.4 RECENT DEVELOPMENTS
13.20 RANDOX LABORATORIES LTD.
  13.20.1 COMPANY SNAPSHOT
  13.20.2 GEOGRAPHICAL PRESENCE
  13.20.3 PRODUCT PORTFOLIO
  13.20.4 RECENT DEVELOPMENTS
13.21 SEEGENE INC.
  13.21.1 COMPANY SNAPSHOT
  13.21.2 REVENUE ANALYSIS
  13.21.3 PRODUCT PORTFOLIO
  13.21.4 RECENT DEVELOPMENTS
13.22 SYSMEX CORPORATION
  13.22.1 COMPANY SNAPSHOT
  13.22.2 REVENUE ANALYSIS
  13.22.3 PRODUCT PORTFOLIO
  13.22.4 RECENT DEVELOPMENTS

14 RELATED REPORTS

List Of Tables

LIST OF TABLES

Table 1 COST OF FEW MULTIPLEX INSTRUMENTS
Table 2 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
Table 3 MIDDLE EAST-AND AFRICA REAGENTS & CONSUMABLES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 4 MIDDLE EAST-AND AFRICA INSTRUMENTS & ACCESSORIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 5 MIDDLE EAST-AND AFRICA INSTRUMENTS & ACCESSORIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 6 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 7 MIDDLE EAST-AND AFRICA NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 8 MIDDLE EAST-AND AFRICA NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 9 MIDDLE EAST-AND AFRICA PROTEIN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 10 MIDDLE EAST-AND AFRICA PROTEIN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 11 MIDDLE EAST-AND AFRICA CELL-BASED MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 12 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
Table 13 MIDDLE EAST-AND AFRICA PROTEIN MICROARRAY IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 14 MIDDLE EAST-AND AFRICA POLYMERASE CHAIN REACTION IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 15 MIDDLE EAST-AND AFRICA MULTIPLEX REAL-TIME PCR IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 16 MIDDLE EAST-AND AFRICA FLOW CYTOMETRY IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 17 MIDDLE EAST-AND AFRICA FLUORESCENCE DETECTION IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 18 MIDDLE EAST-AND AFRICA LUMINESCENCE IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 19 MIDDLE EAST-AND AFRICA OTHERS IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 20 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 21 MIDDLE EAST-AND AFRICA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 22 MIDDLE EAST-AND AFRICA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 23 MIDDLE EAST-AND AFRICA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 24 MIDDLE EAST-AND AFRICA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 25 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 26 MIDDLE EAST-AND AFRICA HOSPITALS IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 27 MIDDLE EAST-AND AFRICA CLINICAL LABORATORIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 28 MIDDLE EAST-AND AFRICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 29 MIDDLE EAST-AND AFRICA RESEARCH INSTITUTES IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 30 MIDDLE EAST-AND AFRICA OTHERS IN MULTIPLEX ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
Table 31 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
Table 32 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
Table 33 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 34 MIDDLE EAST & AFRICA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 35 MIDDLE EAST & AFRICA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 36 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
Table 37 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 38 MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 39 MIDDLE EAST & AFRICA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 40 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 41 SOUTH AFRICA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)
Table 42 SOUTH AFRICA MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 43 SOUTH AFRICA NUCLEIC ACID MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 44 SOUTH AFRICA PROTEIN MULTIPLEX ASSAYS IN MULTIPLEX ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Table 45 SOUTH AFRICA MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
Table 46 SOUTH AFRICA MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 47 SOUTH AFRICA CLINICAL DIAGNOSTICS IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 48 SOUTH AFRICA RESEARCH & DEVELOPMENT IN MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
Table 49 SOUTH AFRICA MULTIPLEX ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
Table 50 REST OF MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017-2026 (USD MILLION)

List Of Figures

LIST OF FIGURES

Figure 1 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET: SEGMENTATION
Figure 2 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET: DATA TRIANGULATION
Figure 3 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET: DROC ANALYSIS
Figure 4 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET: BOTTOM UP APPROACH
Figure 5 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET: TOP DOWN APPROACH
Figure 6 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET: INTERVIEW DEMOGRAPHICS
Figure 7 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET: DBMR MARKET POSITION GRID
Figure 8 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET: THE MARKET CHALLENGE MATRIX
Figure 9 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET: THE CATEGORY VS TIME GRID
Figure 10 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET
Figure 11 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET: SEGMENTATION
Figure 12 USE OF MULTIPLEX ASSAYS IN COMPANION DIAGNOSTICS AND ADVANTAGES OVER SINGLEPLEX AND TRADITIONAL ASSAYS TO DRIVE THE MARKET FOR MULTIPLEX ASSAYS MARKET IN THE FORECAST PERIOD 2019 TO 2026
Figure 13 REAGENTS & CONSUMABLES IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MULTIPLEX ASSAYS MARKET IN 2019 & 2026
Figure 14 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET: BY PRODUCT & SERVICES, 2018
Figure 15 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET: BY TYPE, 2018
Figure 16 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET: BY TECHNOLOGY, 2018
Figure 17 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET: BY APPLICATION, 2018
Figure 18 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET: BY END USER, 2018
Figure 19 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET SNAPSHOT (2018)
Figure 20 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET: BY GEOGRAPHY (2018)
Figure 21 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET: BY GEOGRAPHY (2019-2026)
Figure 22 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET: BY COUNTRY (2018 & 2026)
Figure 23 MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET: BY PRODUCTS & SERVICES (2019 - 2026)
Figure 24 MIDDLE EAST-AND AFRICA MULTIPLEX ASSAYS MARKET: COMPANY SHARE 2018 (%)